AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-201 Cr | ₹124 Cr | ₹28 Cr | ₹-24 Cr | ₹104 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-201 Cr |
Mar2023 | ₹124 Cr |
Mar2022 | ₹28 Cr |
Mar2021 | ₹-24 Cr |
Mar2020 | ₹104 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-201 Cr | Negative | |
Mar2023 | ₹124 Cr | 345.56 | |
Mar2022 | ₹28 Cr | Positive | |
Mar2021 | ₹-24 Cr | Negative | |
Mar2020 | ₹104 Cr | - |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹33,951.6 Cr | 5.7% | -5.3% | 24.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | 5.7% |
-5.3% |
24.4% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses